Aktiesnakken — Februar 2011
-
@rth, re gen, et rygte siger at chefen for drug security er ved at blive fyret uden at en ny søges...ved ikke helt hvordan man skal tolke de
-
t
-
det kan tolkes i den retning at genmab måske ikke vil tage stofferne forbi fase 2
-
og de bliver et drug discovery firma
-
netop...som antydet på R/D dagen
-
det er også den strategi som Neurosearch har anlagt nu. VI skal se det afspejlet i regnskabet og forventningerne for 2011
-
...som kommer på mandag
tillid er godt, kontrol er bedre 
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind